Sex-related Outcomes After Thoracic Endovascular Repair for Intact Isolated Descending Thoracic Aortic Aneurysm: A Retrospective Cohort Study

• Published in: Annals of surgery Vol. 280; no. 1; p. 165
• Main Authors: Allievi, Sara, Rastogi, Vinamr, Yadavalli, Sai Divya, Mandigers, Tim J, Gomez-Mayorga, Jorge L, Deery, Sarah E, Lo, Ruby C, Verhagen, Hence J M, Trimarchi, Santi, Schermerhorn, Marc L
• Format: Journal Article
• Language: English
• Published: United States 01.07.2024
• Subjects: Aged; Aged, 80 and over; Aortic Aneurysm, Thoracic - mortality; Aortic Aneurysm, Thoracic - surgery; Blood Vessel Prosthesis Implantation - methods; Blood Vessel Prosthesis Implantation - mortality; Descending Thoracic Aortic Aneurysm; Endovascular Aneurysm Repair; Endovascular Procedures; Female; Humans; Male; Postoperative Complications - epidemiology; Retrospective Studies; Sex Factors; Treatment Outcome; United States - epidemiology; United States
• ISSN: 1528-1140
• DOI: 10.1097/SLA.0000000000006163

The aim of this study was to evaluate the association between sex and outcomes following thoracic endovascular aortic repair (TEVAR) for intact isolated descending thoracic aortic aneurysms (iiDTAA). Data regarding sex-related long-term outcomes after TEVAR for iiDTAA are limited and conflicting results regarding perioperative outcomes have been reported. We included all TEVAR for iiDTAA between 2014 and 2019 in the Vascular Quality Initiative linked to Medicare claims, allowing reliable assessment of long-term outcome data. Primary outcomes included 5-year mortality, reinterventions, and ruptures of the thoracic aorta. Secondarily, we assessed perioperative outcomes. We identified 685 patients, of which 54% were females. Females had higher aortic size index {females vs males: 3.31 [interquartile range (IQR), 2.81-3.85] cm/m 2 vs 2.93 (IQR, 2.42-3.36) cm/m 2 ; P <0.001}, were more frequently symptomatic (31% vs 20%; P =0.001), had longer procedure time [111 (IQR, 72-165) minutes vs 97 (IQR, 70-146) minutes] and more iliac procedures (16% vs 7.6%; P =0.001). Compared with males, females had similar rates of 5-year mortality [58% vs 53%; hazard ratio (HR), 0.93; 95% CI: 0.71-1.22; P =0.61), reinterventions (39% vs 30%; HR, 1.12; 95% CI: 0.73-1.73; P =0.60), and late ruptures (0.6% vs 1.2%; HR, 0.87; 95% CI: 0.12-6.18; P =0.89). After adjustment, these outcomes remained similar through 5 years. Furthermore, perioperative mortality was not significantly different between sexes (4.1% vs 2.2%; P =0.25), as were rates of any complication as a composite outcome (16% vs 21%; P =0.16), as well as of individual complications (all P >0.05). Our findings suggest that females who undergo TEVAR for iiDTAA have similar 5-year and perioperative outcomes as compared with males.